...
首页> 外文期刊>Archives of orthopaedic and trauma surgery. >Early outcomes of a novel bicruciate-retaining knee system: a 2-year minimum retrospective cohort study
【24h】

Early outcomes of a novel bicruciate-retaining knee system: a 2-year minimum retrospective cohort study

机译:Early outcomes of a novel bicruciate-retaining knee system: a 2-year minimum retrospective cohort study

获取原文
获取原文并翻译 | 示例

摘要

Introduction Bicruciate retaining (BCR) total knee arthroplasty (TKA) was designed to simulate natural knee kinematics and improve proprioception by retaining both the ACL and PCL. While the prospect of the design appears favorable to patients, previous designs have demonstrated modest survivorship rates compared to traditional designs. This study aims to report the early functional outcomes and implant survivorship of a novel BCR design. Materials and methods A multi-center, retrospective study was conducted identifying BCR TKA patients from 2016 to 2017. Patient demographics, quality outcomes, and post-operative complications were collected. A Kaplan-Meier analysis was used to evaluate revision-free survival. Results One-hundred thirty-three patients with a mean follow-up time of 2.35 +/- 0.25 years (range: 2.00-2.87 years) were identified. Patients receiving BCR TKA were, on average, 61.46 +/- 9.27 years-old, obese (BMI = 31.80 +/- 6.01 kg/m(2)), predominantly white (71.4), and female (69.9). The device was most often implanted using standard instruments (85.7) compared to computer-assisted navigation (13.5). Average length-of-stay was 1.77 +/- 0.97 days. Six patients had a reoperation; three (2.5) full revisions occurred for: infection (n = 1), arthrofibrosis (n = 1), and ACL rupture (n = 1); one (0.8) tibial revision occurred for: arthrofibrosis; two (1.5) liner exchanges occurred for: infection (n = 1) and arthrofibrosis (n = 1). Kaplan-Meier survivorship analysis of cumulative failure at 2-year showed a survival rate of 96.2 (95 confidence interval, 91.2-98.4) for all-cause reoperation, 97.3 (91.6-99.1) for aseptic revision, and 100 for mechanical failure. Conclusion Survivorship was 96.2 for all-cause reoperation, 97.3 for aseptic revision, and 100 for mechanical implant failure at 2-years. This novel BCR TKA demonstrated no implant-related complications and excellent survivorship outcomes over 2 years with comparable revision rates to those previously reported in the literature.
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号